Bio2Business is delighted to welcome CARBOGEN AMCIS as an Exhibition Sponsor at BOS Basel 2020. CARBOGEN AMCIS, a member of the Dishman Group, provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development.
To find out more about the full breadth of CARBOGEN AMCIS services and capabilities, click here to visit the website. In addition, click here to view the recent (6th August 2019) press release reporting the successful FDA inspection of the Hunzenschwil (Neuland), Switzerland API manufacturing site. The Hunzenschwil facility is one of CARBOGEN AMCIS’ four sites to offer development and manufacturing facilities for highly potent compounds. It manufactures products according to cGMP standards and is routinely inspected by Swissmedic, the FDA and external customers.